KYNTRA BIO, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for KYNTRA BIO, INC. (KYNB), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are KYNB insiders buying or selling?
In the last 12 months, KYNTRA BIO, INC. insiders reported 2 open-market purchases ($53.6K) and 1 sale ($19.9K) — net buying of $33.7K. Since January 2018, Trabud has recorded 204 Form 4 filings for KYNB: 9 buys ($1.5M) and 195 sells ($132.6M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $33.7K by Thane Wettig (CEO) on Nov 17, 2025. SEC ↗
- The most recent open-market purchase was reported on May 19, 2026 (4 months ago).
Key Statistics (January 2018 – May 19, 2026)
Total Form 4 filings
204
SEC EDGAR
Insider filers
23
Insider buys (9)
$1.5M
Insider sells (195)
$132.6M
Insider sentiment
Net sellingNet insider flow of $131.1M in net selling since January 2018, and $33.7K in net buying over the last 12 months.
Recent KYNB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | Thane Wettig | CEO | Purchase | 2.8K | $7.09 | $19.9K | SEC ↗ |
| May 18, 2026 | Thane Wettig | CEO | Sale | 2.8K | $7.09 | $19.9K | SEC ↗ |
| Nov 17, 2025 | Thane Wettig | CEO | Purchase | 3.7K | $9.12 | $33.7K | SEC ↗ |
| Jul 2, 2025 | James A Schoeneck | Director | Purchase | 23.6K | $5.07 | $119.5K | SEC ↗ |
| Mar 25, 2025 | Thane Wettig | CEO | Purchase | 145.0K | $0.35 | $50.7K | SEC ↗ |
| Mar 24, 2025 | James A Schoeneck | Director | Purchase | 300.0K | $0.35 | $105.0K | SEC ↗ |
| Jun 13, 2024 | Deyaa Adib | Chief Medical Officer | Purchase | 22.1K | $1.17 | $25.9K | SEC ↗ |
| Mar 11, 2024 | Thane Wettig | CEO | Purchase | 50.0K | $1.91 | $95.5K | SEC ↗ |
| Sep 7, 2023 | Jeffrey William Henderson | Director | Sale | 2.0K | $1.03 | $2.1K | SEC ↗ |
| Aug 8, 2023 | Jeffrey William Henderson | Director | Sale | 2.0K | $1.91 | $3.8K | SEC ↗ |
| Jul 14, 2023 | Jeffrey William Henderson | Director | Sale | 2.0K | $2.69 | $5.4K | SEC ↗ |
| Jul 10, 2023 | Enrique A Conterno | Chief Executive Officer | Sale | 1.9K | $2.80 | $5.3K | SEC ↗ |
| Jun 26, 2023 | Thane Wettig | Chief Commercial Officer | Sale | 791 | $16.53 | $13.1K | SEC ↗ |
| Jun 22, 2023 | Thane Wettig | Chief Commercial Officer | Sale | 1.8K | $17.04 | $30.0K | SEC ↗ |
| Jun 16, 2023 | Christine Chung | SVP, China Operations | Sale | 12.5K | $17.19 | $214.9K | SEC ↗ |
| Jun 9, 2023 | Benjamin Cravatt | Director | Sale | 3.9K | $17.17 | $67.7K | SEC ↗ |
| Jun 9, 2023 | Aoife Brennan | Director | Sale | 4.7K | $17.19 | $81.4K | SEC ↗ |
| Jun 9, 2023 | Suzanne Blaug | Director | Sale | 8.5K | $17.20 | $146.6K | SEC ↗ |
| Jun 9, 2023 | Maykin Ho | Director | Sale | 8.5K | $17.44 | $148.6K | SEC ↗ |
| Jun 9, 2023 | Jeffrey L Edwards | Director | Sale | 7.9K | $17.19 | $135.6K | SEC ↗ |
| Jun 9, 2023 | Jeffrey William Henderson | Director | Sale | 7.0K | $17.46 | $122.2K | SEC ↗ |
| Jun 9, 2023 | James A Schoeneck | Director | Sale | 7.1K | $18.03 | $128.0K | SEC ↗ |
| Jun 9, 2023 | Thane Wettig | Chief Commercial Officer | Sale | 1.8K | $17.04 | $30.0K | SEC ↗ |
| Jun 9, 2023 | Juan Graham | Chief Financial Officer | Sale | 1.8K | $16.99 | $30.3K | SEC ↗ |
| Jun 9, 2023 | Christine Chung | SVP, China Operations | Sale | 3.6K | $17.04 | $61.9K | SEC ↗ |
Showing the 25 most recent of 204 Form 4 filings for KYNTRA BIO, INC..
Most active KYNB insiders
- Thomas B Neff40 filings
- Kalevi Kurkijarvi28 filings
- Pat Cotroneo23 filings
- Christine Chung17 filings
- Peony K Yu15 filings
Ask anything about KYNB insider activity
Use Trabud's AI agent to query KYNTRA BIO, INC.'s Form 4 history in plain English — "Show me KYNB CEO purchases this year" or compare it against any other ticker.
Open the AI agentKYNB insider trading FAQ
Are KYNTRA BIO, INC. insiders buying or selling?
In the last 12 months, KYNTRA BIO, INC. insiders reported 2 open-market purchases ($53.6K) and 1 sale ($19.9K) — net buying of $33.7K. Since January 2018, Trabud has recorded 204 Form 4 filings for KYNB: 9 buys ($1.5M) and 195 sells ($132.6M). Over the full record that is net selling of $131.1M.
How many insiders trade KYNB stock?
23 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for KYNTRA BIO, INC.. The most recent filing was accepted on May 19, 2026.
Where does Trabud get KYNB insider trading data?
All KYNB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.